| abstract |
The present invention relates to a compound useful for modulating the activity of a Lyn kinase, and pharmaceutically acceptable salts thereof, and to a formulation comprising such a compound or a pharmaceutically acceptable salt thereof. Specifically, the compound or a pharmaceutically acceptable salt thereof is useful for the treatment and / or prophylaxis of cardiovascular diseases, dyslipidemia, dyslipoproteinemia, disorders of glucose metabolism, metabolic syndrome (i.e., syndrome X), peroxisome proliferator activated receptor- Is useful for the treatment or prevention of diseases or disorders, including sexual dysfunction, type II diabetes, obesity, pancreatitis, hypertension, kidney disease, inflammation or erectile dysfunction. |